Literature DB >> 21035886

The effects of fasting plasma glucose variability and time-dependent glycemic control on the long-term risk of retinopathy in type 2 diabetic patients.

Toshiko Takao1, Takehiko Ide, Hiroyuki Yanagisawa, Masatoshi Kikuchi, Shoji Kawazu, Yutaka Matsuyama.   

Abstract

Long-term fasting plasma glucose (FPG) variability was a risk factor for proliferative diabetic retinopathy (PDR) independent of the mean FPG or HbA1c in people with type 2 diabetes. PDR development was also significantly associated with mean HbA1c more than 5 years earlier and with mean FPG more than 10 years earlier.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21035886     DOI： 10.1016/j.diabres.2010.10.009

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN： 0168-8227            Impact factor:   5.602


  13 in total

Review 1.  Glucose variability, HbA1c and microvascular complications.

Authors:  Jan Škrha; Jan Šoupal; Jan Škrha; Martin Prázný
Journal:  Rev Endocr Metab Disord       Date:  2016-03       Impact factor: 6.514

2.  HbA1c variability is associated with microalbuminuria development in type 2 diabetes: a 7-year prospective cohort study.

Authors:  C C Hsu; H Y Chang; M C Huang; S J Hwang; Y C Yang; Y S Lee; S J Shin; T Y Tai
Journal:  Diabetologia       Date:  2012-08-26       Impact factor: 10.122

3.  Assessment for the Correlation Between Diabetic Retinopathy and Metabolic Syndrome: A Cross-Sectional Study.

Authors:  Qing Sun; Liang Tang; Qiurong Zeng; Mingjun Gu
Journal:  Diabetes Metab Syndr Obes       Date:  2021-04-22       Impact factor: 3.168

Review 4.  Clinical Implications of Glucose Variability: Chronic Complications of Diabetes.

Authors:  Hye Seung Jung
Journal:  Endocrinol Metab (Seoul)       Date:  2015-06

5.  Risk factors of retinopathy in type 2 diabetes mellitus at a tertiary care hospital, Bahawalpur Pakistan.

Authors:  Sadiq Hussain; Muhammad Rashad Qamar; Muhammad Arshad Iqbal; Ameer Ahmad; Ehsan Ullah
Journal:  Pak J Med Sci       Date:  2013-04       Impact factor: 1.088

6.  The relationship between glycemic variability and diabetic peripheral neuropathy in type 2 diabetes with well-controlled HbA1c.

Authors:  Feng Xu; Li-Hua Zhao; Jian-Bin Su; Tong Chen; Xue-Qin Wang; Jin-Feng Chen; Gang Wu; Yan Jin; Xiao-Hua Wang
Journal:  Diabetol Metab Syndr       Date:  2014-12-15       Impact factor: 3.320

7.  The association of long-term glycaemic variability versus sustained chronic hyperglycaemia with heart rate-corrected QT interval in patients with type 2 diabetes.

Authors:  Jian-Bin Su; Xiao-Hua Yang; Xiu-Lin Zhang; Hong-Li Cai; Hai-Yan Huang; Li-Hua Zhao; Feng Xu; Tong Chen; Xing-Bo Cheng; Xue-Qin Wang; Yan Lu
Journal:  PLoS One       Date:  2017-08-28       Impact factor: 3.240

8.  HbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients.

Authors:  Jian-Bin Su; Li-Hua Zhao; Xiu-Lin Zhang; Hong-Li Cai; Hai-Yan Huang; Feng Xu; Tong Chen; Xue-Qin Wang
Journal:  Cardiovasc Diabetol       Date:  2018-03-29       Impact factor: 9.951

9.  Fasting Glucose Variation Predicts Microvascular Risk in ACCORD and VADT.

Authors:  Jin J Zhou; Juraj Koska; Gideon Bahn; Peter Reaven
Journal:  J Clin Endocrinol Metab       Date:  2021-03-25       Impact factor: 5.958

10.  Four-Point Preprandial Self-Monitoring of Blood Glucose for the Assessment of Glycemic Control and Variability in Patients with Type 2 Diabetes Treated with Insulin and Vildagliptin.

Authors:  Andrea Tura; Johan Farngren; Anja Schweizer; James E Foley; Giovanni Pacini; Bo Ahrén
Journal:  Int J Endocrinol       Date:  2015-10-26       Impact factor: 3.257
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.